AI Developed in Graz Speeds Up Cancer Detection

Researchers at TU-Graz in Austria developed an artificial intelligence to accelerate cancer detection in breast and prostate screenings. AIgnostikum, a company spun out of the research project, trained the AI using anonymized data from thousands of MRI scans. Dieter Szolar, the medical director, initiated the project after noticing a lack of similar tools globally, leveraging the availability of large, standardized datasets in the region.

The AI, called RAIDAS, provides an initial assessment within five minutes of a patient’s MRI. This second opinion aims to improve diagnostic accuracy and expedite treatment for patients diagnosed with cancer. AI is already used in medicine to assist with skin cancer diagnosis, and Graz has a history of pioneering work in prostate and breast cancer research.

The team believes they are among the world’s leaders in this field. They hope the technology will quickly deliver certainty to patients and faster access to appropriate care if cancer is present.